Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
132.82 USD | -0.40% |
|
-0.99% | +17.39% |
03:45am | Company earnings: key dates for next week | ![]() |
Jul. 08 | Evercore ISI Adjusts Price Target on Abbott Laboratories to $145 From $140, Maintains Outperform Rating | MT |
Capitalization | 232B 198B 185B 171B 317B 19,906B 356B 2,216B 841B 9,286B 870B 852B 34,064B | P/E ratio 2025 * |
32.9x | P/E ratio 2026 * | 28.9x |
---|---|---|---|---|---|
Enterprise value | 235B 201B 188B 174B 322B 20,200B 361B 2,249B 854B 9,423B 883B 865B 34,567B | EV / Sales 2025 * |
5.28x | EV / Sales 2026 * | 4.86x |
Free-Float |
86.65% | Yield 2025 * |
1.79% | Yield 2026 * | 1.93% |
More valuation ratios
* Estimated data
More news
Last Transcript: Abbott Laboratories
More recommendations
More press releases
More news
1 day | -1.21% | ||
1 week | -1.41% | ||
Current month | -2.79% | ||
1 month | -0.88% | ||
3 months | +4.08% | ||
6 months | +17.73% | ||
Current year | +16.90% |
1 week | 131.47 | ![]() | 135.24 |
1 month | 131.47 | ![]() | 139.06 |
Current year | 110.86 | ![]() | 141.23 |
1 year | 99.71 | ![]() | 141.23 |
3 years | 89.67 | ![]() | 141.23 |
5 years | 89.67 | ![]() | 142.6 |
10 years | 36 | ![]() | 142.6 |
Manager | Title | Age | Since |
---|---|---|---|
Robert Ford
CEO | Chief Executive Officer | 51 | 2020-03-30 |
Philip Boudreau
DFI | Director of Finance/CFO | 52 | 2023-08-31 |
Scott House
CTO | Chief Tech/Sci/R&D Officer | - | 2020-02-29 |
Director | Title | Age | Since |
---|---|---|---|
Robert Alpern
BRD | Director/Board Member | 74 | 2008-10-09 |
Sally Blount
BRD | Director/Board Member | 63 | 2011-12-08 |
Nancy McKinstry
BRD | Director/Board Member | 66 | 2011-12-08 |
Name | Weight | AuM | 1st Jan change | |
---|---|---|---|---|
7.18% | 21 M€ | +3.63% | - |
Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
---|---|---|---|---|---|---|
-1.25% | -1.41% | +30.09% | +21.43% | 232B | ||
-0.54% | -0.04% | +14.78% | -0.79% | 113B | ||
-0.42% | +1.82% | +33.32% | +109.78% | 57.77B | ||
-0.44% | -1.78% | -21.38% | -28.55% | 50.05B | ||
+1.09% | +3.45% | -11.96% | +41.19% | 39.78B | ||
-0.11% | -0.23% | -24.77% | +6.32% | 32.84B | ||
+0.92% | -4.67% | -9.45% | +19.05% | 24.69B | ||
+0.25% | -0.69% | +28.56% | -39.87% | 22.94B | ||
-0.83% | -3.32% | +7.88% | +10.16% | 22.88B | ||
-0.40% | -2.15% | +51.21% | +27.86% | 20.87B | ||
Average | -0.14% | -1.13% | +9.83% | +16.66% | 61.73B | |
Weighted average by Cap. | -0.54% | -0.88% | +16.03% | +19.45% |
2025 * | 2026 * | |
---|---|---|
Net sales | 44.63B 38.12B 35.58B 32.91B 61.07B 3,829B 68.42B 426B 162B 1,786B 167B 164B 6,553B | 48.02B 41.01B 38.28B 35.4B 65.7B 4,119B 73.6B 459B 174B 1,922B 180B 176B 7,049B |
Net income | 7.19B 6.14B 5.73B 5.3B 9.84B 617B 11.02B 68.67B 26.06B 288B 26.96B 26.41B 1,056B | 8.19B 7B 6.53B 6.04B 11.21B 703B 12.56B 78.27B 29.71B 328B 30.73B 30.1B 1,203B |
Net Debt | 3.42B 2.92B 2.73B 2.52B 4.68B 294B 5.25B 32.7B 12.41B 137B 12.84B 12.58B 503B | 1.53B 1.31B 1.22B 1.13B 2.09B 131B 2.34B 14.6B 5.54B 61.16B 5.73B 5.61B 224B |
More financial data
* Estimated data
Employees
114,000
Calendar
Jul. 14
- Détachement de
Date | Price | Change | Volume |
---|---|---|---|
25-07-09 | 132.78 $ | -0.43% | 2,096,268 |
25-07-08 | 133.36 $ | -0.25% | 4,782,570 |
25-07-07 | 133.70 $ | -0.55% | 8,927,599 |
25-07-03 | 134.44 $ | +0.25% | 3,114,335 |
25-07-02 | 134.11 $ | -1.58% | 4,319,684 |
Delayed Quote Nyse, July 09, 2025 at 10:27 am EDT
More quotesSell
Buy

Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
133.36USD
Average target price
141.51USD
Spread / Average Target
+6.11%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- ABT Stock
Select your edition
All financial news and data tailored to specific country editions